title: Anti-cyclic citrullinated peptide antibodies (CCP2) in patients with psoriatic arthritis.
authors.forename: D-D
authors.initials: DD
authors.lastname: Ouédraogo
authors.forename: E
authors.initials: E
authors.lastname: Palazzo
authors.forename: P
authors.initials: P
authors.lastname: Nicaise-Roland
authors.forename: N
authors.initials: N
authors.lastname: Somogyi
authors.forename: S
authors.initials: S
authors.lastname: Grootenboer-Mignot
authors.forename: G
authors.initials: G
authors.lastname: Hayem
authors.forename: O
authors.initials: O
authors.lastname: Meyer
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D015535:Arthritis, Psoriatic / Q000276:immunology*; D001323:Autoantibodies / Q000097:blood*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010456:Peptides, Cyclic / Q000276:immunology*; D012189:Retrospective Studies
chemical_list: D001323:Autoantibodies; D010456:Peptides, Cyclic; C487763:cyclic citrullinated peptide